Incannex Healthcare Inc.
IXHL
$3.85
$0.184.93%
NASDAQ
| 03/31/2026 | 12/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -20.95% | -16.90% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | -39.11% | 1.69% | |||
| Operating Income | 39.11% | -1.69% | |||
| Income Before Tax | 40.45% | -1.78% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 40.45% | -1.78% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 40.45% | -1.78% | |||
| EBIT | 39.11% | -1.69% | |||
| EBITDA | 39.56% | -1.81% | |||
| EPS Basic | 43.82% | 9.62% | |||
| Normalized Basic EPS | 43.84% | 9.61% | |||
| EPS Diluted | 43.82% | 9.62% | |||
| Normalized Diluted EPS | 43.84% | 9.61% | |||
| Average Basic Shares Outstanding | 6.01% | 12.62% | |||
| Average Diluted Shares Outstanding | 6.01% | 12.62% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||